Daily BriefsUnited States

Daily Brief United States: Intel Corp, Snowflake Inc, Nike, Paycom Software, Levi Strauss & Co, Colgate Palmolive Co, Abbott Laboratories and more

In today’s briefing:

  • US CHIPS Act: Long Intel Vs. Short TSMC or UMC?
  • Snowflake FY2Q23 Earnings: High in the Hierarchy of Needs
  • Nike Inc: Innovation For The Pregnant Women Niche & Other Drivers
  • Paycom Software: The Beti Upside
  • Levi Strauss & Co: Collaboration With Reese Cooper & Other Drivers
  • Colgate-Palmolive: What Recent Results Mean For Long-Term Holders
  • Abbott Laboratories: Capacity Expansion For Diabetes Care & Other Drivers

US CHIPS Act: Long Intel Vs. Short TSMC or UMC?

By Vincent Fernando, CFA

  • Intel and Brookefield Asset Management recently announced that they intend to jointly invest US$30 billion into building Intel foundries in Arizona, leveraging on the US CHIPS Act.
  • Although inflation and declining consumer demand continue to affect all chipmakers, U.S. strategic objectives and policies will set Intel on a new growth trajectory and competitive position in our view.
  • A Long Intel/ Short Taiwan semiconductor strategy present a compelling opportunity. We prefer Long Intel vs. Short UMC, however, we expect Long Intel vs. Short TSMC to also be profitable.

Snowflake FY2Q23 Earnings: High in the Hierarchy of Needs

By Aaron Gabin

  • Product revenues beat consensus by 7% and EBIT margins by 5%, while full year guidance was and margins were raised ~2% ahead of consensus.
  • Fears of a consumption model driven slowdown (like Datadog) did not play out, and cRPO growth actually accelerated QoQ to 81%.
  • Data sharing is picking up with larger customers, with 65% of $1M+ customers utilizing stable edges.

Nike Inc: Innovation For The Pregnant Women Niche & Other Drivers

By Ishan Majumdar

  • Nike Inc had another stellar quarter and managed to surpass Wall Street expectations in terms of revenues as well as earnings with plenty of new innovations coming out.
  • A new lifestyle show, Nike Spark Flynit, was launched that introduces the latest innovation of NIKE Running with the Spark cushioning system.
  • This quarter, in Jordan, Luka Doncic debuted his anticipated signature shoe Luka 1, during the NBA Playoff.

Paycom Software: The Beti Upside

By Ishan Majumdar

  • Paycom Software continues to witness a strong demand for automation of management of human capital and self-service payroll with more companies embracing its various solutions, especially Beti.
  • The success to attract new business wins as well as robust demand for employee-focused easy-to-use solutions, drives the company’s revenue growth.
  • We provide the stock of Paycom Software with a ‘Hold’ rating with a revision in the target price.

Levi Strauss & Co: Collaboration With Reese Cooper & Other Drivers

By Ishan Majumdar

  • Levi Strauss & Co continued to see a strong consumer demand in the last quarter as the management continued executing its strategic initiatives that are viewed clearly in the results.
  • Its strategic priorities continue to be focused on margin expansion with a direct-to-consumer (D2C) first approach.
  • We provide Levi Strauss with a ‘Buy’ rating and a revision in the target price.

Colgate-Palmolive: What Recent Results Mean For Long-Term Holders

By Vladimir Dimitrov, CFA

  • Colgate-Palmolive (NYSE:CL) is hardly a business for risk-seeking and short-term oriented investors.
  • While the management has given us a master class in long-term value creation, the share price is also unlikely to make anyone rich quickly.
  • On the contrary, CL is an investment akin for anyone looking for steady value accumulation, superior risk-adjusted returns and a wide moat.

Abbott Laboratories: Capacity Expansion For Diabetes Care & Other Drivers

By Ishan Majumdar

  • Abbott Laboratories had a strong financial performance in the recent quarter led by the development of medical, diagnostics, and pharmaceutical devices.
  • During this quarter, the company is continuing to strengthen its Medical Device portfolio with new innovative products.
  • In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars